Skip to content
EGFR Exon 20 Insertions: Novel Agents
ALK: First Line and Mechanism Of Resistance
Other Driver Mutations: ROS-1, BRAF, MET and RET
Non Driver NSCLC: The Immunotherapy Strategy
Small Cell Lung Cancer: Targeting This Difficult Target
Novel Advances in T-Cell NHL Therapies
Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy
CLL: Therapeutic Advances in 2024
Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)
De Novo Acute Myeloid Leukemia
CAR-T Cell Therapy in Lymphomas: 7-Years Later
Acquired Inhibitors in Cancer: State-of-the Art Management
Sequencing Therapy in Relapsed/Refractory Myeloma Patients
Role of Pharmacist in Vaccination: Challenges and Opportunities
Diabetes Management in the Face of Healthcare Disparities
Cancer Care Disparities in Puerto Rico (Part 1)
Malignant Hematology and Use of Bi-specifics in Puerto Rico
Leveraging NCODA Resources to Manage Patients on Oral Oncolytics
Obesity Management with Incretin Therapies: Considerations for Patients with and without Type 2 Diabetes
Post Neoadjuvant Chemotherapy and the Axilla
Denovo Metastatic Breast and the Role of Surgery
Breast Cancer – Transgender Construction and Deconstruction
LCIS and ILC – Old Story with New Concerns
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
